ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

Cancer Training Programs Fairing Fairley Well

December 1, 1989

Eight Years Later:In A Change of Heart, LCA Endorses NLST

April 18, 2014

Guest Editorial: Guideline Promises to End Twenty-Year War Over Mass Screening for Prostate Cancer

May 24, 2013

NCI, NSABP Launch Taxifin Trial For Prevention Of Breast Cancer

May 8, 1992

Antibody Targeting PD-L1 Shows Fast Tumor Shrinkage

May 31, 2013

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005